[ Price : $8.95]
Congressional negotiators boost FDAs funding by about 17.5% on an annualized basis over FY 2008 available funds under a House-Sena...[ Price : $8.95]
AdvaMed says it hopes an FDA guidance on interactive medical device review wont stifle innovative interactions already underway in...[ Price : $8.95]
OSI Pharmaceuticals and Genentech say patients with hepatic impairment should be monitored closely when taking Tarceva.[ Price : $8.95]
Researchers say two Boehringer-Ingelheim COPD drugs are associated with an increased risk of cardiovascular events.[ Price : $8.95]
FDA accepts for review an ARCA biopharma NDA for bucindolol, an investigational beta-blocker and vasodilator indicated for treatin...[ Price : $8.95]
Federal Register Notice: FDA plans enforcement action against unapproved topical drug products containing papain due to potentiall...[ Price : $8.95]
Federal Register Notice: FDA plans enforcement action against unapproved ophthalmic balanced salt solutions for irrigating the eye...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Allez Spine, Mallinckrodt, Omega Supply, and Suarez Corp.